Is Moderna stock a buy after unveiling new test results for its omicron-blocking booster shot? Is MRNA stock a buy right now?
Known for its Covid-19 vaccine, Moderna Inc. ( MRNA , Financial) holds a strong position in both clinical development and commercial manufacturing scale for mRNA vaccines. Currently, the company has 4

Pfizer (PFE) Seeks FDA Nod for Bivalent COVID Jab in Infants

01:52pm, Tuesday, 06'th Dec 2022 Zacks Investment Research
Pfizer (PFE) and partner BioNTech seek label expansion to use their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine in young children under five years.
Pfizer asked a federal court in Boston on Monday to dismiss Moderna's lawsuit seeking monetary damages for alleged patent violations related to the Covid vaccine.
Pfizer Inc (NYSE:PFE) and BioNTech have moved to countersue rival Moderna Therapeutics Inc in a legal battle over the development of each company's respective Covid-19 vaccines.  Moderna sued the du

Should Investors Buy Pfizer (PFE) & Moderna (MRNA) Stock for 2023?

01:28am, Tuesday, 06'th Dec 2022 Zacks Investment Research
Much of the social and economic post-pandemic recovery is accredited to Covid-19 vaccine makers Pfizer (PFE) and Moderna (MRNA). Investors may be wondering if these stocks will continue to be strong i
Much of the social and economic post-pandemic recovery is accredited to Covid-19 vaccine makers Pfizer (PFE) and Moderna (MRNA). Investors may be wondering if these stocks will continue to be strong i
Those trends are hurting companies' productivity, which will lower earnings and, in turn, stock prices.

Is Veeva Systems Stock a Buy Now?

02:03pm, Saturday, 03'rd Dec 2022 The Motley Fool
The cloud-based customer relationship management company faces a lot of near-term headwinds.

Moderna Stock: Buy, Sell, or Hold in 2023?

11:30am, Thursday, 01'st Dec 2022 The Motley Fool
Moderna has reached an important turning point.

Moderna Stock: Buy, Sell, or Hold in 2023?

06:30am, Thursday, 01'st Dec 2022
Moderna has reached an important turning point.

Novavax (NVAX) COVID Jab Gets Expanded Label in WHO's EUL

03:20pm, Wednesday, 30'th Nov 2022 Zacks Investment Research
The WHO updates Emergency Use Listing (EUL) for Novavax's (NVAX) COVID-19 vaccine to include its use as a primary series in adolescents and for use as a booster dose in adults.
Tech layoffs are in the news, but life sciences companies seem to be doing better.
The head of the International Monetary Fund on Tuesday joined the chorus of people urging China to adopt a more targeted approach to the coronavirus pandemic.

3 Reasons Pfizer Stock Will Crush the Broader Market in 2023

11:00am, Tuesday, 29'th Nov 2022 The Motley Fool
Pfizer's revenue growth is far from over.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE